CTAS

Insider announces Sirius AI™, the world's most comprehensive Generative AI solution for CX, making marketing teams 60% more productive

Retrieved on: 
Mardi, septembre 26, 2023
Zen, OpenAI, WhatsApp, Craft, Virginity, Marketing, Synthetic media, CX, Samsung, Human, AOV, Attention, Customer experience, GAP, NLP, Language, Sirius, CNN, MAC, CTAS, Singapore Airlines, Allianz, Automation, Machine learning, Marks & Spencer, Generative, Growth, AI, Coca-Cola, Burger King, VIP, CLTV, Customer service, Sales, Medical device, Online shopping, Insider, Adidas, Lenovo, Vodafone

NEW YORK and LONDON, Sept. 26, 2023 /PRNewswire/ -- Insider today announced the launch of Sirius AI™, the world's most comprehensive, patent-pending, Generative AI solution for customer experience that combines the power of large language models and machine learning—to make marketing teams 60% more productive and drive new levels of growth.

Key Points: 
  • I am thrilled to announce the launch of Sirius AI ™ - the world's most comprehensive and end-to-end Generative AI solution for CX," said Hande Cilingir, Co-Founder & CEO at Insider.
  • Our patent-pending Generative AI solutions are designed to make marketing teams more productive and efficient while helping them reach new levels of growth with high-performing customer experiences."
  • Sirius AI™ intelligently automates tasks such as segmentation, journey development, content creation, and optimization to achieve the desired outcome.
  • Unlike other Generative AI solutions, Sirius AI ™ offers automation, machine learning, and large language models at every level of customer experience creation, making it the world's most robust and comprehensive Generative AI solution for Customer Experience.

Biocytogen Officially Launches RenMice® Series

Retrieved on: 
Vendredi, septembre 15, 2023
Health, General Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Monoclonal antibody, Antigen, Immunization, Human, Drug development, Therapy, Phla–Pherá languages, PMHC cellular microarray, TIL, HLA, G protein-coupled receptor, CMC, Immune tolerance, MHC, NK, Multimedia, Toxicity, Antibody, Medication, TCR, Knob, Service provider, TILS, HKEX, CTAS, Collection, KIH, Risk, Drug discovery, Epitope, Mouse, Mutagenesis, Spacecraft, Hook effect, Virus, CDR3, Safety, Vaccine

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.

Key Points: 
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.
  • The RenMice® series encompasses five strains of fully human antibody/TCR mice: RenMab™, RenLite®, RenNano®, RenTCR™, and RenTCR-mimic™.
  • View the full release here: https://www.businesswire.com/news/home/20230915794363/en/
    RenMice Series and Their Drug Discovery Applications (Graphic: Business Wire)
    Since their successive release in 2019, Biocytogen’s RenMice series has received global recognition in the biopharmaceutical and biotechnology field.
  • As of June 30, 2023, Biocytogen has entered into RenMice licensing agreements with 20 biopharmaceutical/biotechnology companies worldwide; 42 target-nominated antibody development projects have been initiated.

Biocytogen Officially Launches RenMice® Series

Retrieved on: 
Vendredi, septembre 15, 2023
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Monoclonal antibody, Antigen, Immunization, Human, Drug development, Therapy, Phla–Pherá languages, PMHC cellular microarray, TIL, HLA, G protein-coupled receptor, CMC, Immune tolerance, MHC, NK, Multimedia, Toxicity, Antibody, Medication, TCR, Knob, Service provider, TILS, HKEX, CTAS, Collection, KIH, Risk, Drug discovery, Epitope, Mouse, Mutagenesis, Spacecraft, Hook effect, Virus, CDR3, Safety, Vaccine

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.

Key Points: 
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.
  • The RenMice® series encompasses five strains of fully human antibody/TCR mice: RenMab™, RenLite®, RenNano®, RenTCR™, and RenTCR-mimic™.
  • View the full release here: https://www.businesswire.com/news/home/20230914583107/en/
    RenMice Series and Their Drug Discovery Applications (Graphic: Business Wire)
    Since their successive release in 2019, Biocytogen’s RenMice series has received global recognition in the biopharmaceutical and biotechnology field.
  • As of June 30, 2023, Biocytogen has entered into RenMice licensing agreements with 20 biopharmaceutical/biotechnology companies worldwide; 42 target-nominated antibody development projects have been initiated.

Forbes names Cintas among America’s Best-in-State Employers

Retrieved on: 
Jeudi, septembre 14, 2023
Retail, Other Professional Services, Office Products, Family, Human Resources, Consumer, Other Construction & Property, Professional Services, Construction & Property, People with Disabilities, Environmental, Social and Governance (ESG), Building Systems, DEI (Diversity, Equity and Inclusion), LGBTQ+, Workforce, Human resources, Partnership, Employment, Friends, Culture, Multimedia, Corporation, CTAS, DEI, Spouse, Statista, Environment, Nursing, Management, Cintas

Cintas Corporation (Nasdaq: CTAS) has been named to Forbes’ America’s Best-in-State Employers 2023 list for the second year in a row.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS) has been named to Forbes’ America’s Best-in-State Employers 2023 list for the second year in a row.
  • View the full release here: https://www.businesswire.com/news/home/20230914979951/en/
    Cintas was named to Forbes' America's Best-in-State Employers for the second year in a row.
  • (Graphic: Business Wire)
    The award distinguishes the best employers in the United States, based on criteria such as working conditions, diversity, salary, potential for development and company image, and the likelihood of employees recommending their employers to friends and family.
  • “Our 44,500 employee-partners across North America are central to our success,” said Max Langenkamp, Cintas Senior Vice President of Human Resources and Chief Diversity Officer.

Cintas Honors 10 EVS Technicians as 2023 C.A.P.E. Award Winners

Retrieved on: 
Mercredi, septembre 13, 2023
Other Health, General Health, Professional Services, Other Construction & Property, Infectious Diseases, Hospitals, Small Business, Construction & Property, Other Professional Services, COVID-19, Building Systems, Health, AHE, Partnership, Trainer, Coronavirus, Infection, Rubbermaid, EVS, Ecosystem, Patient, Houston, Hospital, Nature, Sanitation, CTAS, Fungal infection, Virus, Nursing, Health care, Cintas

In honor of Environmental Services (EVS) week, which is being recognized September 10-16, Cintas Corporation (Nasdaq: CTAS) is proud to announce the winners of its 2023 C.A.P.E.

Key Points: 
  • In honor of Environmental Services (EVS) week, which is being recognized September 10-16, Cintas Corporation (Nasdaq: CTAS) is proud to announce the winners of its 2023 C.A.P.E.
  • These awards were established to recognize professionals “Cleaning to Advance the Patient Experience.” C.A.P.E.
  • Ten Environmental Services (EVS) technicians at the frontline of patient care and sanitation were nominated and selected based on the quality of their service and dedication.
  • "We received hundreds of submissions from across the country about inspiring EVS technicians who are dedicated to providing clean, safe places for patients, their families and other staff members," said Chad Poeppelmeier, Cintas Vice President of Healthcare.

Cintas Corporation Announces Webcast for First Quarter Fiscal Year 2024 Results

Retrieved on: 
Mardi, septembre 12, 2023
Other Professional Services, Office Products, Other Manufacturing, Textiles, Specialty, Professional Services, Manufacturing, Retail, Webcast, CTAS, Cintas, Corporation, Eastern Time Zone, Cryptocurrency, Broadcasting

Cintas Corporation (Nasdaq:CTAS) today announced that it will release fiscal year 2024 first quarter results on Tuesday, September 26, 2023.

Key Points: 
  • Cintas Corporation (Nasdaq:CTAS) today announced that it will release fiscal year 2024 first quarter results on Tuesday, September 26, 2023.
  • The Company will conduct a conference call to address the financial results.
  • A live webcast of the call will be available to individual investors and the public beginning at 10:00 a.m., Eastern Time, on Tuesday, September 26, 2023.
  • For those unable to listen to the live webcast, a replay will be available on the Company's website beginning approximately two hours after the completion of the live call and will remain available for two weeks.

Cintas Corporation rises on 2023 Forbes Global 2000 list

Retrieved on: 
Jeudi, septembre 7, 2023
Other Consumer, Construction & Property, Human Resources, Professional Services, Philanthropy, Consumer, Environmental, Social and Governance (ESG), Other Philanthropy, Other Construction & Property, Other Professional Services, Global 2000, CTAS, Cintas, FactSet, Corporation, Multimedia, Culture, Video game, Pharmaceutical industry

Cintas Corporation (Nasdaq: CTAS) has been named to 2023 Forbes’ Global 2000 list , which ranks the largest companies in the world.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS) has been named to 2023 Forbes’ Global 2000 list , which ranks the largest companies in the world.
  • 884 on the Global 2000 list, rising from No.
  • View the full release here: https://www.businesswire.com/news/home/20230907034035/en/
    Cintas has been named to 2023 Forbes' Global 2000 list.
  • (Graphic: Business Wire)
    To determine its Global 2000 ranking, Forbes uses data from FactSet Research Systems to screen the largest public global companies using four criteria: sales, profits, assets, and market value.

OptiMargin Releases WHATif Cloud, API Version

Retrieved on: 
Jeudi, août 31, 2023
Software, Data Analytics, Finance, Asset Management, Data Management, Professional Services, Technology, Mobile, Wireless, Cloud, Forecasting, Commodity trading advisor, Commodity, API, SPAN, CTAS, RIAS, CME Group, IRM, ICE, Privacy, Video game, Cryptocurrency

OptiMargin, a margin analytics software provider, announces the release of WHATif Cloud and API Versions compatible with the SPAN 2 margin methodology developed by CME Group.

Key Points: 
  • OptiMargin, a margin analytics software provider, announces the release of WHATif Cloud and API Versions compatible with the SPAN 2 margin methodology developed by CME Group.
  • WHATif is designed for predictability, forecasting and potential reduction of costs during margin volatility and rising cost of capital.
  • The free version, available for download on https://optimargin.com/ is cloud-based, significantly upgraded based on user feedback and compatible with the SPAN 2 methodology.
  • The paid version includes access to over 60 exchanges, dedicated API access as well as additional security and privacy measures.

Cintas Adds Forbes Best Employers for Women to List of Honors

Retrieved on: 
Vendredi, août 25, 2023
DEI (Diversity, Equity and Inclusion), Public Policy, Government, Public Safety, Sports, Consumer, Other Construction & Property, Manufacturing, Construction & Property, Specialty, Fashion, Law Enforcement, Emergency Services, Environmental, Social and Governance (ESG), Retail, Other Professional Services, Human Resources, Professional Services, Philanthropy, Other Consumer, Women, Other Philanthropy, Other Manufacturing, Textiles, Workforce, Medical device, Human resources, Johnson & Johnson, Partnership, Culture, Parent, Woman, Multimedia, Research, Mother, Shred-it, Retirement, Corporation, Document management system, CTAS, Business Wire, Statista, Family, Female, Corporate development, Nursing, Management, Cintas

Cintas Corporation (Nasdaq: CTAS) has earned further recognition for its workplace practices after being named recently to Forbes’ 2023 Best Employers for Women list.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS) has earned further recognition for its workplace practices after being named recently to Forbes’ 2023 Best Employers for Women list.
  • Forbes’ annual ranking was created to help women identify companies that serve their needs and for companies to evaluate their own support of women in their workplaces.
  • (Graphic: Business Wire)
    “We are very intentional and deliberate about our culture here at Cintas,” said Todd Schneider, Cintas President and CEO.
  • And I'm honored and humbled to be able to be part of Cintas, and to be a part of bringing attention to the women at Cintas.”

Snappy Kraken Unleashes AI to Turbocharge Advisors’ Email Marketing Efforts

Retrieved on: 
Mardi, août 22, 2023
Technology, Content Marketing, Other Communications, Marketing, Communications, Software, Networks, Internet, Digital Marketing, Artificial Intelligence, Kraken, Pressure, Martech, Digital, AI, Intelligence, CTAS, Human, Head, Sales

Magic Image: Empowering advisors to quickly generate unique images, enhancing the visual appeal and hyper-personalization of their emails.

Key Points: 
  • Magic Image: Empowering advisors to quickly generate unique images, enhancing the visual appeal and hyper-personalization of their emails.
  • Smart Headings: Instantly transforming monotone text by creating engaging and intriguing alternatives that fit advisors’ brand and voice.
  • "Our AI-powered email builder functions like a highly energized professional writer, marketer and designer, minus the accompanying overhead,” noted Angel Gonzalez , Snappy Kraken’s chief marketing officer.
  • Throughout its journey, Snappy Kraken has consistently prioritized data-driven decision-making, a principle that led to deliberate testing and assessment of AI's potential impact.